Citius Pharmaceuticals
CTXR
CTXR
7 hedge funds and large institutions have $926K invested in Citius Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Millennium Management
New York
|
$0 |
| 2 |
2
Goldman Sachs
New York
|
$0 |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$6K |
| 4 |
4
Morgan Stanley
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $820K | 210,131 | +210,131 | New |
|
|
RJA
2
Raymond James & Associates
St Petersburg,
Florida
| $46K | 12,000 | +12,000 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $43K | 11,050 | +11,050 | New |
|
|
CP
4
Corbenic Partners
Bethlehem,
Pennsylvania
| $7K | 1,811 | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $6K | 1,505 | -384 | -20% |
|
|
DCM
6
Delpha Capital Management
New York
| $3K | 739 | +739 | New |
|
|
HFM
7
Hartford Financial Management
Hartford,
Connecticut
| $1K | 500 | +500 | New |
|
|
8
Millennium Management
New York
| – | – | -19,983 | Closed |
|
|
9
Goldman Sachs
New York
| – | – | -11,574 | Closed |
|
|
10
Morgan Stanley
New York
| – | – | -210 | Closed |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | – | – | – |
|